Lucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ... [Yahoo! Finance]
Lucid Diagnostics Inc. (LUCD)
Company Research
Source: Yahoo! Finance
Gross Margin per Test: Over 90%. Cash at Quarter End: $14.5 million as of September 30th. Quarterly Burn Rate: $10.4 million. Convertible Debt: Notice given to redeem the remainder of the outstanding note. Shares Outstanding: Approximately 59.3 million shares as of the latest update. Non-GAAP Net Loss per Share: $0.20, consistent with previous quarters. Operating Expenses (Non-GAAP): $11.3 million for the third quarter. Pro Forma Revenue from Submitted Claims: Nearly $7 million. Cash Increase from New Investments: Expected to increase cash by about $13.2 million net of payoff. Warning! GuruFocus has detected 4 Warning Signs with LUCD. Release Date: November 13, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Lucid Diagnostics Inc ( NASDAQ:LUCD ) reported a 20% increase in quarterly revenue, reaching a record $1.2 million for the third quarter. The company has completed a comprehensive body of clinical
Show less
Read more
Impact Snapshot
Event Time:
LUCD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUCD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUCD alerts
High impacting Lucid Diagnostics Inc. news events
Weekly update
A roundup of the hottest topics
LUCD
News
- Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $3.00 price target on the stock.MarketBeat
- Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.MarketBeat
- Lucid Diagnostics Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]Seeking Alpha
- Lucid Diagnostics reports Q3 results [Seeking Alpha]Seeking Alpha
- Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial ResultsPR Newswire
LUCD
Earnings
- 11/13/24 - Miss
LUCD
Sec Filings
- 11/13/24 - Form 8-K
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- LUCD's page on the SEC website